|FOR IMMEDIATE RELEASE||For More Information, Contact:|
|July 2, 2013||Jim Drewitz, Investor Relations|
The Contract Is Valued At Approximately $750,000.
ARMSTRONG, Iowa, July 2, 2013 – Art’s Way Manufacturing Co., Inc. (NASDAQ: ARTW), announces its wholly-owned subsidiary, Art’s Way Scientific, Inc. (www.buildingsforscience.com), has been awarded a contract for six modular swine buildings from the Texas Department of Criminal Justice. The modular buildings will be used in support of the Correctional Unit’s Swine Farrowing/Nursery/Finishing Operations. The contract was awarded in a competitive bidding environment and is valued at approximately $750,000.
Dan Palmer, President of Art’s Way Scientific said, “We are honored to have the opportunity to design, manufacture and install these six AG swine buildings for the State of Texas. They are a valued and repeat customer. It demonstrates the strength of our team and our unique capabilities within the modular AG buildings industry. These buildings fit our customer’s need perfectly because they create the ideal environment for swine and the people who work with them. Our ‘turnkey solution’ is ideal for environments where the site must be closely controlled for security reasons. Our modular AG buildings are completely climate controlled, easy to clean and sanitize, and include the most advanced swine equipment including boar isolation, gestation, farrowing, nursery, finishing, feed study and show pigs – www.artsway-scientific.com/ag-buildings/hog-care. Our ability to design, construct and install ‘ready to use swine units’ in short period of time, made this a very easy decision for Texas.”
J. Ward McConnell, Jr., Chairman of the Board, said, “We are beginning to see an increased interest for our modular agricultural buildings particularly in the Hog and Dairy industries. As a result of these contracts and other bids in the pipeline, as well as a very healthy farm income which has encouraged farmers to purchase new equipment and expand operations, we are anticipating Art’s Way’s consolidated revenue, income and gross margins to improve in the balance of fiscal 2013.“
About Art’s Way Scientific, Inc. – Buildings For Science –
Art’s Way Scientific, Inc. is a wholly owned subsidiary of Art’s Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health, and food safety, hog and calf care and security requirements. Art’s Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers’ critical requirements. For more information, visit our website at www.buildingsforscience.com
About Art’s Way Manufacturing, Inc.
Art’s Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, round hay balers, plows, hay and forage equipment, manure spreaders, reels for combines and swathers, snow blowers and dump trailers, top and bottom drive augers, as well as pressurized tanks and vessels, and modular animal confinement buildings and laboratories. After-market service parts are also an important part of the Company’s business. The Company has three reporting segments: agricultural products; pressurized tanks and vessels; and modular buildings.
For More Information, Contact: Jim Drewitz, Investor Relations
Or visit the Company’s website at www.artsway-mfg.com/
This news release includes “forward-looking statements” within the meaning of the federal securities laws. Statements of anticipated future results, including but not limited to the anticipated revenues and timeframes discussed in this release and expected consolidated results of operations, are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, unforeseen delays in production and installation, unforeseen contract disputes, customer demand for the Company’s products, domestic and international economic conditions and other risks detailed from time to time in the Company’s Securities and Exchange Commission filings. Actual results may differ markedly from management’s expectations. The Company cautions readers not to place undue reliance upon any such forward-looking statements.